Prosecution Insights
Last updated: August 17, 2026

Examiner: KOMATSU, LI N

Tech Center 1600 • Art Units: 1654 1658 1676

This examiner grants 60% of resolved cases

Performance Statistics

59.6%
Allow Rate
At TC average
729
Total Applications
+71.0%
Interview Lift
962
Avg Prosecution Days
Based on 671 resolved cases, 2023–2026

Rejection Statute Breakdown

5.9%
§101 Eligibility
13.1%
§102 Novelty
30.6%
§103 Obviousness
28.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19422266 HYDROXYPROLINE-FREE HYDROLYZED COLLAGEN PEPTIDES AND METHODS OF MAKING AND USING THE SAME Non-Final OA Rochal Technologies, LLC
18101233 MEANS AND METHODS FOR TREATING COPPER-RELATED DISEASES Final Rejection IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC.
17754712 COMPOSITIONS AND METHODS FOR TREATING LIBERIBACTER DISEASES AND OTHER BACTERIAL DISEASES Non-Final OA The Regents of the University of California
18258636 COMPOSITIONS COMPRISING CYCLOTIDES AND OTHER INSECTICIDAL PEPTIDES AND USES THEREOF Non-Final OA SYNGENTA CROP PROTECTION AG
18574671 PEPTIDE HAVING ANTICANCER ACTIVITY, AND USE THEREOF Non-Final OA Korea University Research and Business Foundation
18762553 SERINE PROTEINASE INHIBITORS: SERP-1 AND SERP-1 RCL-DERIVED PEPTIDES EFFECT ON MICROBIOME COMPOSITION AND USES THEREOF Final Rejection Arizona Board of Regents on Behalf of Arizona State University
17599211 USE OF CYCLO(HIS-PRO) (CHP) FOR PREVENTING, AMELIORATING, OR TREATING FIBROSIS Final Rejection SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18138118 FERRITIN NANOCAGE FUSED WITH PD-L1-BINDING PEPTIDE 1 AND USE THEREOF AS ANTICANCER IMMUNOTHERAPY AGENT Non-Final OA KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
17843418 PD-1-DECORATED NANOCAGES AND USES THEREOF Final Rejection KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month